Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Radiology provider Akumin highlights ‘robust’ growth in PET/CT volumes with no signs of slowing

The Plantation, Florida, company saw volumes from the modality leap 16.1% on a same-store basis when compared to Q1 of 2022, leaders said. 

Thumbnail

Solar cell materials could make medical imaging safer, more cost-effective

Not only could the materials reduce patient exposure to ionizing radiation, they also could reduce costs associated with traditional X-ray equipment, according to newly published research in Nature Communications.

M&A mergers and acquisitions business deal

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

1 in 3 physicians sued during career, with radiologists ‘significantly’ more likely to face litigation

Over 40% of radiologists said they’ve been sued during the course of their career, according to new survey data from the American Medical Association. 

Thumbnail

Radiology data analytics vendor Quinsite raises $5.5M in series A financing

The funds will fuel growth initiatives and expansion in other specialties such as pathology, anesthesiology, orthopedics and emergency medicine. 

Thumbnail

1 in 3 cardiologists have been sued, though they often win when it happens

Overall, 31.2% of U.S. physicians say they have been sued. When looking at only cardiologists, the percentage is slightly higher.

Money bankruptcy debt liquidation

Private equity-backed radiology provider Envision Healthcare to file for bankruptcy: Report

The move is expected to wipe out the entire investment of KKR, which first took the publicly traded physician group private in a 2018 $5.5B buyout. 

Researchers question FFR-CT’s value compared to other cardiac imaging options

FFR-CT has grown in popularity due its ability to provide noninvasive evaluations of patients being considered for revascularization procedures. According to a new study in JACC: Cardiovascular Imaging, however, stress imaging strategies may still provide more value in certain scenarios.